Samsung Medical Center is a tertiary hospital located in Irwon-Dong of Gangnam-Gu, Seoul, South Korea. SMC is composed of Samsung Seoul Hospital, Kangbook Samsung Hospital, Samsung Changwon Hospital, and Samsung Life Sciences Research Center. SMC was founded on November 9, 1994.

During the past decade, Samsung Medical Center conducted 1253 clinical trials. In the 10-year time frame, 1253 clinical trials started and 312 clinical trials were completed, i.e. on average, 24.9% percent of trials that started reached the finish line to date. In the past 5 years, 577 clinical trials started and 227 clinical trials were completed. i.e. 39.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Samsung Medical Center" #1 sponsor was "Samsung Medical Center" with 650 trials, followed by "Hoffmann-La Roche" with 125 trials sponsored, "Pfizer" with 68 trials sponsored, "Janssen Research & Development, LLC" with 46 trials sponsored and "Celgene" with 46 trials sponsored. Other sponsors include 949 different institutions and companies that sponsored additional 373 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Samsung Medical Center" #1 collaborator was "Samsung Medical Center" with 35 trials as a collaborator, "Merck Sharp & Dohme LLC" with 27 trials as a collaborator, "AstraZeneca" with 26 trials as a collaborator, "Seoul National University Hospital" with 26 trials as a collaborator and "Asan Medical Center" with 22 trials as a collaborator. Other collaborators include 790 different institutions and companies that were collaborators in the rest 395 trials.

According to Clinical.Site data, the most researched conditions in "Samsung Medical Center" are "Breast Cancer" (56 trials), "Gastric Cancer" (45 trials), "Stroke" (36 trials), "Coronary Artery Disease" (32 trials) and "Multiple Myeloma" (29 trials). Many other conditions were trialed in "Samsung Medical Center" in a lesser frequency.

Most popular intervention types in "Samsung Medical Center" are "Drug" (1267 trials), "Device" (174 trials), "Other" (164 trials), "Procedure" (133 trials) and "Biological" (128 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (209 trials), "Atezolizumab" (53 trials), "Paclitaxel" (47 trials), "Pembrolizumab" (43 trials) and "Carboplatin" (41 trials). Other intervention names were less common.

The vast majority of trials in "Samsung Medical Center" are 1669 trials for "All" genders, 122 trials for "Female" genders and 77 trials for "Male" genders.

Currently, there are 620 active trials in "Samsung Medical Center". 7 are not yet recruiting, 360 are recruiting, 246 are Active, not recruiting, and 7 are Enrolling by invitation. In total, there were 851 completed trials in Samsung Medical Center, 5 suspended trials, and 113 terminated clinical trials to date.

Out of the total trials that were conducted in Samsung Medical Center, 261 "Phase 1" clinical trials were conducted, 498 "Phase 2" clinical trials and 562 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 122 trials, and there were also 272 trials that are defined as “Not Applicable".

Samsung Medical Center has several departments that took part in Clinical trials: "Samsung Medical Center Clinical Trial Pharmacy" - 7 trials, "Division of Gastroenterology, Department of Medicine, Samsung Medical Center" - 7 trials, "Samsung Medical Center, Department of Neurology" - 6 trials, "Cardiac and Vascular Center; Samsung Medical Center" - 6 trials, "Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine" - 3 trials, "Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine" - 3 trials, "Samsung Medical Centre; Division of Hematology/Oncology" - 29 trials, "Samsung Medical Center, Organ Transplant Center" - 2 trials, "Department of Ophthalmology, Samsung Medical Center" - 2 trials, "Samsung Medical Center; Nephrology Department" - 2 trials, "Samsung Medical Center/Division of Nephrology" - 2 trials